Industry news
Sellas Life Sciences to acquire Galena Therapeutics.
Sellas Life Sciences will acquire Galena Therapeutics assuring Sellas of a NASDAQ listing and a way forward to fund galinpepimut-S which is due to enter Phase III trials for AML and Mesothelioma.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
